Related Experiment Video
Updated: May 7, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
An Aggressive Case of Thymic Lymphoepithelial Carcinoma Complicated by Cytokine Release Syndrome: A Case Report
Louis G Filipiak1, Nyembezi L Dhliwayo1, Koosha Paydary1
1Rush University Medical Center, Chicago, Illinois, USA, rush.edu.
Abstract:
Thymic lymphoepithelial carcinomas (TLECs) are a rare primary thymic cancer best described by lymphoplasmacytic infiltration of the thymic stroma. Though only accounting for 1.3%-6% of thymic carcinomas, the distribution of TLECs is bimodal, peaking around ages 14 and 48 and affecting males to females in a 2:1 ratio. Due to their rarity and aggressive nature, they often present at later stages and can be primarily treated with a combination of chemotherapy and radiation. While several paraneoplastic syndromes have been reported with TLECs, cytokine release syndrome (CRS) has been observed in several cases. This particular case illustrates a metastatic TLEC patient that was treated with chemotherapy and complicated by CRS.
More Related Videos
11:11Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Cushing Syndrome II: Pathophysiology
Cytotoxic Edema: Pathophysiology